VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,511,000 | -55.8% | 136,975 | -41.8% | 0.24% | -33.1% |
| Q4 2016 | $3,420,000 | +112.8% | 235,528 | +259.9% | 0.37% | +76.8% |
| Q3 2016 | $1,607,000 | -18.9% | 65,441 | -33.5% | 0.21% | -10.8% |
| Q2 2016 | $1,982,000 | +17.1% | 98,428 | +53.0% | 0.23% | -63.2% |
| Q1 2016 | $1,692,000 | +632.5% | 64,324 | +2736.2% | 0.63% | +473.6% |
| Q4 2015 | $231,000 | -91.3% | 2,268 | -84.8% | 0.11% | -84.9% |
| Q3 2015 | $2,660,000 | -20.7% | 14,910 | -11.7% | 0.73% | -39.5% |
| Q1 2015 | $3,354,000 | +1431.5% | 16,884 | +1002.1% | 1.20% | +947.8% |
| Q4 2014 | $219,000 | -66.8% | 1,532 | -69.4% | 0.12% | -46.3% |
| Q1 2014 | $660,000 | – | 5,008 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |